Manuel Villareal

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Infant origins of childhood asthma associated with specific molds

Tiina Reponen, James E. Lockey, David I. Bernstein et al. · Journal of Allergy and Clinical Immunology · 2012 · 208 citations · Full text

Medicine, Child Health, Pediatrics +16

Is it traffic type, volume, or distance? Wheezing in infants living near truck and bus traffic

Patrick Ryan, Grace K. LeMasters, Jocelyn M. Biagini Myers et al. · Journal of Allergy and Clinical Immunology · 2005 · 191 citations · Full text

Public Health, Child Health, Pediatrics +14

A Comparison of Proximity and Land Use Regression Traffic Exposure Models and Wheezing in Infants

Patrick Ryan, Grace K. LeMasters, Pratim Biswas et al. · Environmental Health Perspectives · 2006 · 179 citations · Full text

Public Health, Environmental Sciences, Health Sciences +17

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15